|
|
Substance Name: Ranitidine Hydrochloride [USP:JAN]
RN: 66357-59-3
UNII: BK76465IHM
InChIKey: GGWBHVILAJZWKJ-UHFFFAOYSA-N
Note
- A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
Molecular Formula
- C13-H22-N4-O3-S.Cl-H
Molecular Weight
- 350.8687
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
Classification Codes
- Antagonist
- Antagonist (to Histamine H2 Receptors)
- Histamine H2 Receptor Antagonists
- Human Data
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Ranitidine Hydrochloride [USP:JAN]
Synonyms
- 1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-, monohydrochloride
- AH 19065
- Alquen
- Alter-H2
- Alvidina
- Apo-Ranitidin
- Artomil
- Azuranit
- CCRIS 5268
- Coralen
- Coralen [inj.]
- Digestosan
- EINECS 266-333-0
- Ergan
- Esofex
- Fendibina
- Gastridina
- Gastrolav
- Kuracid
- Label
- Lake
- Logat
- Mideran
- N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride
- Neugal
- Noktome
- Normon
- Novo-Radinine
- Nu-Ranit
- Pep-Rani
- Quadrin
- Quantor
- Quantor [inj.]
- Radin
- RAN
- Ran H2
- Ran Lich
- Rani 2
- Rani AbZ
- Rani-BASF
- Rani-nerton
- Rani-Puren
- Rani-Q
- Rani-Sanorania
- Raniberl
- Raniberta
- Ranibloc
- ranic
- Ranicux
- Ranidil
- Ranidin
- Ranidura
- Ranifur
- Ranifur [inj.]
- Ranigasan
- Ranigast
- Ranigen
- Ranilonga
- Ranimerck
- Ranisan
- Ranitab
- Ranitic
- Ranitidin
- Ranitidin 1A Pharma
- Ranitidin AL
- Ranitidin Arcana
- Ranitidin Atid
- Ranitidin AWD
- Ranitidin Basics
- Ranitidin Duncan
- Ranitidin Dyna
- Ranitidin Helvepharm
- Ranitidin Heumann
- Ranitidin Hexal
- Ranitidin Merck
- Ranitidin Millet
- Ranitidin NM
- Ranitidin Normon
- Ranitidin PB
- Ranitidin Stada
- Ranitidin von ct
- Ranitidin-Cophar
- Ranitidin-Isis
- Ranitidin-ratiopharm
- Ranitidina predilu Grif
- Ranitidina Tamarang
- Ranitidine
- Ranitidine hydrochloride
- Ranitin
- Ranitine
- Ranobel
- Ranuber
- Regalil
- Renatac
- Rozon
- Rubiulcer
- Santanol
- Serviradine
- Tanidina
- Toriol
- Trigger [Drug]
- Ulcecur
- Ulcirex
- Ulcodin
- Ulcolind Rani
- Ulcosan
- Ulsaven
- UNII-BK76465IHM
- Viserul
- Zandid
- Zantac
- Zantac 150
- Zantac 25
- Zantac 300
- Zantac 75
- Zantac efferdose
- Zantac in plastic container
- Zantarac
Systematic Names
- 1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-, monohydrochloride
- N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitrovinylidenediamine hydrochloride
- Ranitidine hydrochloride
Registry Numbers
CAS Registry Number
- 66357-59-3
FDA UNII
- BK76465IHM
Related Registry Number
- 66357-35-5 (Parent)
System Generated Number
- 0066357593
Molecular Formulas
Molecular Formula
- C13-H22-N4-O3-S.Cl-H
Molecular Formula Fragments
- C13-H22-N4-O3-S
- Cl-H
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1HInChIKey
GGWBHVILAJZWKJ-UHFFFAOYSA-NSmiles
Cl.CNC(=C[N+](=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | oral | 2400mg/kg/43W (2400mg/kg) | SKIN AND APPENDAGES (SKIN): SWEATING: OTHER CARDIAC: PULSE RATE BEHAVIORAL: COMA | American Journal of Diseases of Children. Vol. 139, Pg. 442, 1985. |
dog | LDLo | oral | 3gm/kg (3000mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING BEHAVIORAL: ATAXIA | Journal of Toxicological Sciences. Vol. 8(Suppl, |
man | TDLo | intravenous | 714mg/kg/5M-C (714mg/kg) | CARDIAC: CHANGE IN RATE | American Journal of Gastroenterology. Vol. 83, Pg. 332, 1988. |
man | TDLo | oral | 8571ug/kg/2D- (8.571mg/kg) | BLOOD: EOSINOPHILIA KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | American Journal of Kidney Diseases. Vol. 22, Pg. 337, 1993. |
man | TDLo | oral | 30mg/kg/1W-I (30mg/kg) | BEHAVIORAL: HEADACHE | New England Journal of Medicine. Vol. 310, Pg. 1602, 1984. |
man | TDLo | oral | 87mg/kg/4D-I (87mg/kg) | CARDIAC: PULSE RATE BEHAVIORAL: EXCITEMENT BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Annals of Internal Medicine. Vol. 108, Pg. 493, 1988. |
mouse | LD50 | intramuscular | 400mg/kg (400mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
mouse | LD50 | intraperitoneal | 300mg/kg (300mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
mouse | LD50 | intravenous | 60mg/kg (60mg/kg) | LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of Toxicological Sciences. Vol. 8(Suppl, |
mouse | LD50 | oral | 1100mg/kg (1100mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Journal of Toxicological Sciences. Vol. 8(Suppl, |
mouse | LD50 | subcutaneous | 630mg/kg (630mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
rabbit | LD50 | intravenous | 109mg/kg (109mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
rabbit | LD50 | oral | 2500mg/kg (2500mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
rat | LD50 | intramuscular | 1530mg/kg (1530mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
rat | LD50 | intraperitoneal | 441mg/kg (441mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
rat | LD50 | intravenous | 85mg/kg (85mg/kg) | LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of Toxicological Sciences. Vol. 8(Suppl, |
rat | LD50 | oral | 4190mg/kg (4190mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Oyo Yakuri. Pharmacometrics. Vol. 26, Pg. 147, 1983. |
rat | LD50 | subcutaneous | 1700mg/kg (1700mg/kg) | Yakkyoku. Pharmacy. Vol. 36, Pg. 521, 1985. | |
women | TDLo | intravenous | 27mg/kg/8D-I (27mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Archives of Internal Medicine. Vol. 152, Pg. 2325, 1992. |
women | TDLo | multiple routes | 174mg/kg/33D- (174mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS | American Journal of Kidney Diseases. Vol. 22, Pg. 333, 1993. |
women | TDLo | oral | 3mg/kg (3mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | New England Journal of Medicine. Vol. 310, Pg. 1601, 1984. |
women | TDLo | oral | 9mg/kg/36H-I (9mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | American Journal of Psychiatry. Vol. 143, Pg. 257, 1985. |
women | TDLo | oral | 12mg/kg/2D-I (12mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Allergy. Vol. 51, Pg. 659, 1996. |